Skip to main content
. 2020 Jul 8;16(3):347–366. doi: 10.1007/s11302-020-09711-4

Fig. 10.

Fig. 10

Combined pyrimidine metabolic rate–limiting enzymes have significant prognostic effects of in lung cancer. a Unsupervised clustering heatmap showed the division of two clusters of lung cancer patients by the expression levels of pyrimidine metabolic rate–limiting enzymes in GSE30219 dataset. Each line represented one patient. b The Kaplan-Meier plotter demonstrated the different clinical outcomes of those two clusters of lung cancer patients in GSE30219 dataset. The log-rank test was used to determine the overall survival P value. c Unsupervised clustering heatmap showed the division of two clusters of lung cancer patients by the expression levels of pyrimidine metabolic rate–limiting enzymes in TCGA LUAD dataset. d The Kaplan-Meier plotter demonstrated the different clinical outcomes of those two clusters of lung cancer patients in TCGA LUAD dataset. The log-rank test was used to determine the overall survival P value